Thiopurine metabolites variations during co-treatment with aminosalicylates for inflammatory bowel disease: Effect of N-acetyl transferase polymorphisms-Reference-Cited by-同舟云学术

Thiopurine metabolites variations during co-treatment with aminosalicylates for inflammatory bowel disease: Effect of N-acetyl transferase polymorphisms

Published:2015 Issue:12 Volume:21 Page:3571
ISSN:1007-9327
Container-title:World Journal of Gastroenterology
language:en
Short-container-title:WJG

Author:

Stocco Gabriele

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,General Medicine

Reference42 articles.

1. Dubinsky MC, Lamothe S, Yang HY, Targan SR, Sinnett D, Théorêt Y, Seidman EG. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology 2000;118:705-713.

2. Lowry PW, Franklin CL, Weaver AL, Szumlanski CL, Mays DC, Loftus EV, Tremaine WJ, Lipsky JJ, Weinshilboum RM, Sandborn WJ. Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide. Gut 2001;49:656-664.

3. Thiopurine therapy in inflammatory bowel disease patients: Analyses of two 8-year intercept cohorts

4. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis

5. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of Crohn´s disease pharmacotherapy in the child and adult population;Klinická farmakologie a farmacie;2023-07-10

2. Laboratory considerations for pharmacogenomic testing;Clinical Decision Support for Pharmacogenomic Precision Medicine;2022

3. No Benefit of Continuing 5-Aminosalicylates in Patients with Crohn’s Disease Treated with Anti-metabolite Therapy;Digestive Diseases and Sciences;2021-11-19

4. No benefit of continuing vs stopping 5-aminosalicylates in patients with ulcerative colitis escalated to anti-metabolite therapy;Alimentary Pharmacology & Therapeutics;2020-06-23

5. Azathioprine Biotransformation in Young Patients with Inflammatory Bowel Disease: Contribution of Glutathione-S Transferase M1 and A1 Variants;Genes;2019-04-04